E-LIB Suche - Ergebnisse für: Corey, G.R.

1

1261Geographical variations in the incidence of CIED infect..:

Kennergren, C ; Poole, J E ; Wilkoff, B L...
EP Europace. 22 (2020) Supplement_1 - p. , 2020

2

2289. Bacterial Causes of Acute Bacterial Skin and Skin Str..:

Huang, David B ; Noviello, Stephanie S ; Balser, Barbara...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S784-S785 , 2019

Link: https://doi.org/10.1093/..

3

Reply to DiNubile:

Corey, G. R. ; Boucher, H. W. ; Stryjewski, M. E.
Clinical Infectious Diseases. 60 (2015) 8 - p. 1291-1292 , 2015

Link: https://doi.org/10.1093/..

4

Evaluation of Patient Reported outcomes (Pro) In Obese Pati..:

Corey, G.R. ; Gupta, K. ; Henry, E...
Value in Health. 18 (2015) 3 - p. A243 , 2015

Link: https://doi.org/10.1016/..

5

Analysis of Phase 3 telavancin nosocomial pneumonia data ex..:

Torres, A. ; Rubinstein, E. ; Corey, G. R...
Journal of Antimicrobial Chemotherapy. 69 (2014) 4 - p. 1119-1126 , 2014

Link: https://doi.org/10.1093/..

6

99 A Single Dose of Oritavancin Compared to 7 to 10 Days of..:

Pollack Jr., C.V. ; Corey, G.R. ; Good, S....
Annals of Emergency Medicine. 64 (2014) 4 - p. S36 , 2014

Link: https://doi.org/10.1016/..

7

Editorial Commentary: NOVA Score to Predict Endocarditis in..:

Stryjewski, M. E. ; Corey, G. R.
Clinical Infectious Diseases. 60 (2014) 4 - p. 536-538 , 2014

Link: https://doi.org/10.1093/..

8

252 Efficacy Outcomes by Lesion Type in Studies of a Single..:

Pollack Jr., C.V. ; Corey, G.R. ; Good, S....
Annals of Emergency Medicine. 64 (2014) 4 - p. S90 , 2014

Link: https://doi.org/10.1016/..

9

Potential Role for Telavancin in Bacteremic Infections Due ..:

Corey, G. R. ; Rubinstein, E. ; Stryjewski, M. E...
Clinical Infectious Diseases. 60 (2014) 5 - p. 787-796 , 2014

Link: https://doi.org/10.1093/..

10

P75 OUTCOME OF EARLY VALVE SURGERY COMPARED TO MEDICAL TREA..:

Baršić, B. ; Chu, V.H. ; Krajinović, V....
International Journal of Antimicrobial Agents. 41 (2013) - p. S29 , 2013

Link: https://doi.org/10.1016/..

11

Methicillin-Resistant Staphylococcus aureus: An Evolving Pa..:

Stryjewski, M. E. ; Corey, G. R.
Clinical Infectious Diseases. 58 (2013) suppl 1 - p. S10-S19 , 2013

Link: https://doi.org/10.1093/..

12

Efficacy of telavancin in patients with specific types of c..:

Stryjewski, M. E. ; Barriere, S. L. ; O'Riordan, W....
Journal of Antimicrobial Chemotherapy. 67 (2012) 6 - p. 1496-1502 , 2012

Link: https://doi.org/10.1093/..

13

Telavancin versus Vancomycin for Hospital-Acquired Pneumoni..:

Rubinstein, E. ; Lalani, T. ; Corey, G. R....
Clinical Infectious Diseases. 52 (2011) 1 - p. 31-40 , 2011

Link: https://doi.org/10.1093/..

14

Reply to Tarchini:

Rubinstein, E. ; Corey, G. R. ; Stryjewski, M. E...
Clinical Infectious Diseases. 52 (2011) 11 - p. 1391-1392 , 2011

Link: https://doi.org/10.1093/..

15

Reply to Spellberg:

Corey, G. R. ; Stryjewski, M. E.
Clinical Infectious Diseases. 53 (2011) 12 - p. 1309-1310 , 2011

Link: https://doi.org/10.1093/..